Chimeric Feline Coronaviruses That Encode Type II Spike Protein on Type I Genetic Background Display Accelerated Viral Growth and Altered Receptor Usage

被引:42
作者
Tekes, Gergely [2 ]
Hofmann-Lehmann, Regina [3 ]
Bank-Wolf, Barbara [2 ]
Maier, Reinhard [1 ]
Thiel, Heinz-Juergen [2 ]
Thiel, Volker [1 ]
机构
[1] Kantonal Hosp St Gallen, Inst Immunobiol, CH-9007 St Gallen, Switzerland
[2] Univ Giessen, Inst Virol, D-6300 Giessen, Germany
[3] Univ Zurich, Clin Lab, Vetsuisse Fac, Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
INFECTIOUS-PERITONITIS; AMINOPEPTIDASE-N; VIRUS; CANINE; CATS; DETERMINANTS; PATHOGENESIS; REPLICATION; ASSOCIATION; MACROPHAGES;
D O I
10.1128/JVI.01568-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Persistent infection of domestic cats with feline coronaviruses (FCoVs) can lead to a highly lethal, immunopathological disease termed feline infectious peritonitis (FIP). Interestingly, there are two serotypes, type I and type II FCoVs, that can cause both persistent infection and FIP, even though their main determinant of host cell tropism, the spike (S) protein, is of different phylogeny and displays limited sequence identity. In cell culture, however, there are apparent differences. Type II FCoVs can be propagated to high titers by employing feline aminopeptidase N (fAPN) as a cellular receptor, whereas the propagation of type I FCoVs is usually difficult, and the involvement of fAPN as a receptor is controversial. In this study we have analyzed the phenotypes of recombinant FCoVs that are based on the genetic background of type I FCoV strain Black but encode the type II FCoV strain 79-1146 S protein. Our data demonstrate that recombinant FCoVs expressing a type II FCoV S protein acquire the ability to efficiently use fAPN for host cell entry and corroborate the notion that type I FCoVs use another main host cell receptor. We also observed that recombinant FCoVs display a large-plaque phenotype and, unexpectedly, accelerated growth kinetics indistinguishable from that of type II FCoV strain 79-1146. Thus, the main phenotypic differences for type I and type II FCoVs in cell culture, namely, the growth kinetics and the efficient usage of fAPN as a cellular receptor, can be attributed solely to the FCoV S protein.
引用
收藏
页码:1326 / 1333
页数:8
相关论文
共 34 条
[1]   Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon [J].
Cervantes-Barragan, Luisa ;
Zuest, Roland ;
Weber, Friedernann ;
Spiegel, Martin ;
Lang, Karl S. ;
Akira, Shizuo ;
Thiel, Volker ;
Ludewig, Burkhard .
BLOOD, 2007, 109 (03) :1131-1137
[2]   Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease [J].
De Groot-Mijnes, JDF ;
van Dun, JM ;
van der Most, RG ;
de Groot, RJ .
JOURNAL OF VIROLOGY, 2005, 79 (02) :1036-1044
[3]   An update on canine coronaviruses: Viral evolution and pathobiology [J].
Decaro, Nicola ;
Buonavoglia, Canio .
VETERINARY MICROBIOLOGY, 2008, 132 (3-4) :221-234
[4]   Replication of feline coronaviruses in peripheral blood monocytes [J].
Dewerchin, HL ;
Cornelissen, E ;
Nauwynck, HJ .
ARCHIVES OF VIROLOGY, 2005, 150 (12) :2483-2500
[5]   Type I feline coronavirus spike glycoprotein falls to recognize aminopeptidase N as a functional receptor on feline cell lines [J].
Dye, Charlotte ;
Temperton, Nigel ;
Siddell, Stuart G. .
JOURNAL OF GENERAL VIROLOGY, 2007, 88 :1753-1760
[6]   Mouse Hepatitis Virus Liver Pathology Is Dependent on ADP-Ribose-1"-Phosphatase, a Viral Function Conserved in the Alpha-Like Supergroup [J].
Eriksson, Klara Kristin ;
Cervantes-Barragan, Luisa ;
Ludewig, Burkhard ;
Thiel, Volker .
JOURNAL OF VIROLOGY, 2008, 82 (24) :12325-12334
[7]  
Eriksson Klara Kristin, 2008, V454, P237, DOI 10.1007/978-1-59745-181-9_18
[8]  
Haijema Bert Jan, 2007, P183
[9]   Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus [J].
Herrewegh, AAPM ;
Smeenk, I ;
Horzinek, MC ;
Rottier, PJM ;
de Groot, RJ .
JOURNAL OF VIROLOGY, 1998, 72 (05) :4508-4514
[10]   Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA [J].
Hertzig, T ;
Scandella, E ;
Schelle, B ;
Ziebuhr, J ;
Siddell, SG ;
Ludewig, B ;
Thiel, V .
JOURNAL OF GENERAL VIROLOGY, 2004, 85 :1717-1725